All News

22/04 REPEAT & CORRECT : Amazon Launches Program for GLP-1 Weight-Loss Drugs Article on April 21 DJ
22/04 Delay in Medicare pilot for obesity drugs may not hurt near-term demand, analysts say RE
22/04 NOVO NORDISK : Deutsche Bank gives a Neutral rating ZD
22/04 European health chief says EU is at 'a critical point' in ensuring new drug access RE
22/04 Trump administration is indefinitely delaying a Medicare pilot program to cover weight-loss drugs - Axios RE
22/04 European health chief says review of new weight-loss pill will conclude by summer RE
22/04 Pfizer GLP-1 weight loss drug available for pre-order in China RE
22/04 European health regulator chief says EU needs more say in securing access to new drugs  RE
22/04 ABB overtakes Novo Nordisk in market capitalization FW
22/04 Nordic Equities in North America - Ericsson Slides 2.2 Percent FW
22/04 PRESS DIGEST-Wall Street Journal - April 22 RE
22/04 Amazon.com Launches Program for GLP-1 Weight-Loss Drugs With One Medical -- Update DJ
22/04 Health Care Up After UnitedHealth Earnings -- Health Care Roundup DJ
22/04 Amazon.com to Offer Program for GLP-1 Weight-Loss Drugs DJ
21/04 UnitedHealth flags challenges in Medicare obesity drug pilot RE
21/04 European Equities Traded in the US as American Depositary Receipts Sharply Lower in Tuesday Trading MT
21/04 European shares dip as US-Iran tensions weigh on sentiment RE
21/04 Nordic Equities in North America - Astra Zeneca slips 1.1 percent FW
20/04 European Stocks Fall Sharply in Monday Trading as Hopes of Middle East Ceasefire Dim MT
20/04 Yara nominates former BP chair Helge Lund to lead board RE
20/04 NOVO NORDISK : JP Morgan remains Neutral ZD
20/04 Novo Nordisk A/S - share repurchase programme GL
20/04 Helge Lund nominated as new Chairman of Yara FW
20/04 Yara International Names New Chairman MT
20/04 Yara nominates Helge Lund as chair of board RE
No results for this search